Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy

被引：0
|
作者：
Terzic, T.
Teira, P.
Cournoyer, S.
Peuchmaur, M.
Sartelet, H.
机构：
[1] Ctr Hosp Univ St Justine, Montreal, PQ, Canada
[2] Hop Univ Robert Debre, Paris, France
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1869
引用
收藏
页码：449A / 449A
页数：1
相关论文
共 50 条
  • [1] Expression of Disialoganglioside GD2 in Neuroblastomas of Patients Treated with Immunotherapy
    Terzic, T.
    Teira, P.
    Cournoyer, S.
    Peuchmaur, M.
    Sartelet, H.
    LABORATORY INVESTIGATION, 2013, 93 : 449A - 449A
  • [2] Expression of Disialoganglioside (GD2) in Neuroblastic Tumors: A Prognostic Value for Patients Treated With Anti-GD2 Immunotherapy
    Terzic, Tatjana
    Cordeau, Martine
    Herblot, Sabine
    Teira, Pierre
    Cournoyer, Sonia
    Beaunoyer, Mona
    Peuchmaur, Michel
    Duval, Michel
    Sartelet, Herve
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2018, 21 (04) : 355 - 362
  • [3] Disialoganglioside GD2 directed immunotherapy of neuroblastoma
    Lode, H.
    Siebert, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S75 - S75
  • [4] Expression of disialoganglioside GD2 in breast cancer subtypes
    Gass, Paul
    Kailayangiri, Sareetha
    Huebner, Hanna
    Ruebner, Matthias
    Hartmann, Arndt
    Haeberle, Lothar
    Voelkl, Simon
    Mackensen, Andreas
    Landgraf, Laura
    Schulz-Wendtland, Ruediger
    Farwick, Nicole
    Roessig, Claudia
    Beckmann, Matthias
    Fasching, Peter Andreas
    Erber, Ramona
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 20 - 20
  • [5] PATTERNS OF EXPRESSION OF DISIALOGANGLIOSIDE GD2 IN PEDIATRIC SARCOMAS
    Murphy, Lindsey
    Albert, Catherine
    Park, Julie
    Hawkins, Doug
    Rudzinski, Erin
    Pinto, Navin
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [6] Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
    Erber, Ramona
    Kailayangiri, Sareetha
    Huebner, Hanna
    Ruebner, Matthias
    Hartmann, Arndt
    Haeberle, Lothar
    Meyer, Julia
    Voelkl, Simon
    Mackensen, Andreas
    Landgraf, Laura
    Geppert, Carol, I
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Farwick, Nicole
    Rossig, Claudia
    Gass, Paul
    CANCERS, 2021, 13 (21)
  • [7] EXPRESSION OF GD2 GANGLIOSIDE BY UNTREATED PRIMARY HUMAN NEUROBLASTOMAS
    WU, ZL
    SCHWARTZ, E
    SEEGER, R
    LADISCH, S
    CANCER RESEARCH, 1986, 46 (01) : 440 - 443
  • [8] Disialoganglioside GD2 Expression in Pediatric Rhabdomyosarcoma: A Case Series and Review of the Literature
    Saraf, Amanda J.
    Dickman, Paul S.
    Hingorani, Pooja
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (02) : 118 - 120
  • [9] Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
    Nazha, Bassel
    Inal, Cengiz
    Owonikoko, Taofeek K.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Disialoganglioside GD2 as a therapeutic target for human diseases
    Suzuki, Maya
    Cheung, Nai-Kong V.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (03) : 349 - 362
12345